Faculty

Institution

Unit

Venue

Jen-Jane Liu, M.D.

Associate Professor of Urology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Urology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Urology

Division Of Pediatric Urology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Jen-jane Liu, M.d. is currently serving as a Biostatistics Shared Resources Associate Professor of Urology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jen-Jane Liu, M.D.

Oregon Health & Science University

Associate Professor of Urology School of Medicine

You can click a keyword to filter the displayed items

urology oncology surgery bladder cancer prostate cancer surgical oncology cancer care genitourinary cancers cancer treatment prostatic disease medicine cancer research medical imaging cancer imaging blood transfusion radical cystectomy breast cancer mri-guided radiation therapy outcomes research urological research molecular cancer transfusion medicine neurology tumor biology neuroradiology jama oncology hemostasis urogenital radiology cancer management frailty neoadjuvant chemotherapy detalimogene voraplasmid adverse outcomes cancer cells medicinal research reconstructive microsurgery gastrointestinal surgery cancer biology benign prostatic hyperplasia adverse events oncologic imaging image guidance retrospective analysis radical prostatectomy direct mri-guided biopsy muscle-invasive urothelial carcinoma cellular therapy experimental medicine infection control sexual abuse head trauma rehabilitation magnetic resonance colorectal cancer lymphoid neoplasia signaling pathways gene function prognostic evaluation perioperative care diagnostic neuroradiology hypoxia (medicine) clinical infection disease progression surgical training clinical management trauma surgery traumatology medical ultrasound reconstructive urology cisplatin-based neoadjuvant chemotherapy tumor-infiltrating lymphocytes oncogenic signaling blockade predicting response cisplatin neoadjuvant chemotherapy bladder cancer patients pi-rads category 4 prostate mri

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase I/II Study of Detalimogene Voraplasmid Intravesical Monotherapy for Patients With High-Risk Non-Muscle Invasive Bladder Cancer. EMJ Urology (2025)

phase i/ii studybladder cancerradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologyjama oncology

Evolution Toward Early Stent Removal and Reduced Antibiotic Prophylaxis Post-Cystectomy. Canadian Journal of Urology (2025)

surgeryearly stent removalantibioticslumen-apposing metal stent

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. medRxiv (2025)

immunologymolecular cancerimmune checkpoint inhibitorsurologycancer discoverycancer immunotherapycancer genomicsgenitourinary cancerskidney cancermolecular associationsjama oncologyimmunotherapy

Ip05-39 Associations Between Protein Biomarkers and Adverse Pathologic Features in Mri-Mapped Prostate Cancers: An Interim Analysis. The Journal of Urology (2025)

biomarkersan interim analysisbiomarker discoveryurologycancer discoveryprostatic diseasemolecular diagnosticsprognostic biomarkerspathologyprostate cancerclinical proteomics

LEGEND: A Phase 1/2 Study of Detalimogene Voraplasmid (Eg-70), an Intravesical Monotherapy for Patients With High-Risk Non–Muscle-Invasive Bladder Cancer (Nmibc).. Journal of Clinical Oncology (2025)

Jen-Jane LiuRaj SatkunasivamRian J. DicksteinShreyas JoshiSam S. ChangGautam JayramNeal D. ShoreYair LotanAnne K. SchuckmanRaj PruthiAnthony CheungKatherine Hubert ChanChristine TosoneScott JohnsonVignesh PackiamChristine IbiliborWassim KassoufAshish M. KamatJohn Arthur TaylorGary D. Steinberg

detalimogene voraplasmidbladder cancerintravesical monotherapycancer researchurologyoncologyclinical researchcancer treatment

Mp19-19 Interim Analysis of the “Shutter Speed” Mri Model to Detect Clinically Significant Prostate Cancer. The Journal of Urology (2025)

radiologycancer careradiation oncologyurologyprostatic diseasemedical imagingcancer imagingmri-guided radiation therapyoncologybiomedical imagingmp19-19 interim analysisprostate canceroncologic imaging

Preliminary Results From Legend: A Phase 2 Study of Detalimogene Voraplasmid (Eg-70), a Novel, Non-Viral Intravesical Gene Therapy for Patients With Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer (Nmibc) With Carcinoma in Situ (Cis).. Journal of Clinical Oncology (2025)

John Arthur TaylorShreyas JoshiRaj SatkunasivamRian J. DicksteinAmirali SalmasiYair LotanScott JohnsonRaj PruthiChristine TosoneAnne K. SchuckmanJen-Jane Liu

gene therapydetalimogene voraplasmidbladder cancerurologycancer treatment

P2-08 Legend: A Phase 1/2 Study of Eg-70 (Detalimogene Voraplasmid), a Novel, Non-Viral Intravesical Gene Therapy for Patients With Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ (Cis). The Journal of Urology (2024)

Susan KalotaShreyas JoshiMatthew BuiRian DicksteinJen-Jane LiuYair LotanScott JohnsonJohn TaylorRichard BryceChristine TosoneJoseph ZabellGary SteinbergGordon Brown

gene therapydetalimogene voraplasmidbladder cancercancer carecancer managementcancer researchnovel therapiesurologycancer genomicsgenitourinary cancersbreast canceroncologycancer treatmenthealth sciences

Testicular Germ Cell Tumors With Venous Tumor Thrombus: Prevalence, Presentation, and Management. European Urology Focus (2024)

Sophia Y ChahineKhalid Y AlkhatibGevorg ArakelyanClaire BuxtonGianluca GiannariniRobert J HamiltonSarah K HoltJean-Christophe BernhardDi Maria JiangDaniel LinJen-Jane LiuBrandon ManleyViraj A MasterVsevolod MatveevAndrea NecchiVignesh T PackiamSunil H PatelTaylor PeakCharles C PeytonPhillip M PierorazioGagan PrakashKeyan SalariWade J SextonNirmish SinglaPhilippe E SpiessSarah P Psutka

venous tumor thrombusgerm cellstumor biologyurologyclinical presentation

Mp32-06 Early Stent Removal After Radical Cystectomy. The Journal of Urology (2023)

surgerygastrointestinal surgerylumen-apposing metal stentmedical devicesminimally invasive procedures

1
2
3
4
5
6
7
10 / page

Jen-Jane Liu, M.D.

Associate Professor of Urology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Urology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Urology

Division Of Pediatric Urology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Jen-jane Liu, M.d. is currently serving as a Biostatistics Shared Resources Associate Professor of Urology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jen-Jane Liu, M.D.

Oregon Health & Science University

Associate Professor of Urology School of Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase I/II Study of Detalimogene Voraplasmid Intravesical Monotherapy for Patients With High-Risk Non-Muscle Invasive Bladder Cancer. EMJ Urology (2025)

phase i/ii studybladder cancerradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologyjama oncology

Evolution Toward Early Stent Removal and Reduced Antibiotic Prophylaxis Post-Cystectomy. Canadian Journal of Urology (2025)

surgeryearly stent removalantibioticslumen-apposing metal stent

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. medRxiv (2025)

immunologymolecular cancerimmune checkpoint inhibitorsurologycancer discoverycancer immunotherapycancer genomicsgenitourinary cancerskidney cancermolecular associationsjama oncologyimmunotherapy

Ip05-39 Associations Between Protein Biomarkers and Adverse Pathologic Features in Mri-Mapped Prostate Cancers: An Interim Analysis. The Journal of Urology (2025)

biomarkersan interim analysisbiomarker discoveryurologycancer discoveryprostatic diseasemolecular diagnosticsprognostic biomarkerspathologyprostate cancerclinical proteomics

detalimogene voraplasmidbladder cancerintravesical monotherapycancer researchurologyoncologyclinical researchcancer treatment

Mp19-19 Interim Analysis of the “Shutter Speed” Mri Model to Detect Clinically Significant Prostate Cancer. The Journal of Urology (2025)

John Arthur TaylorShreyas JoshiRaj SatkunasivamRian J. DicksteinAmirali SalmasiYair LotanScott JohnsonRaj PruthiChristine TosoneAnne K. SchuckmanJen-Jane Liu

gene therapydetalimogene voraplasmidbladder cancerurologycancer treatment

Susan KalotaShreyas JoshiMatthew BuiRian DicksteinJen-Jane LiuYair LotanScott JohnsonJohn TaylorRichard BryceChristine TosoneJoseph ZabellGary SteinbergGordon Brown

Testicular Germ Cell Tumors With Venous Tumor Thrombus: Prevalence, Presentation, and Management. European Urology Focus (2024)

venous tumor thrombusgerm cellstumor biologyurologyclinical presentation

Mp32-06 Early Stent Removal After Radical Cystectomy. The Journal of Urology (2023)

surgerygastrointestinal surgerylumen-apposing metal stentmedical devicesminimally invasive procedures

1
2
3
4
5
6
7
10 / page